Aspire Biopharma Holdings, Inc.
Aspire Biopharma Holdings, Inc.
Aspire Biopharma Holdings, Inc. (ASBP) — SEC Financial Statements & Analysis
Aspire Biopharma Holdings, Inc. (ASBP) files its annual 10-K and quarterly 10-Q reports directly with the SEC. The financial data below is sourced as-filed from EDGAR — balance sheet, income statement, and cash flow as reported, without normalization or third-party adjustments.
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Financial Statements
Values in Millions ($) | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Common Class A | - | - | - | - | - | - | - | - | - | - | - | 7 | |||||
Assets | |||||||||||||||||
Cash | 6 | 1 | 2 | 0 | 1 | 0 | - | - | 0 | - | 0 | 0 | |||||
Cash And Cash Equivalents At Carrying Value | 6 | - | - | - | - | - | - | - | - | - | - | - | |||||
Assets Current | |||||||||||||||||
Assets Current | 7 | 1 | 2 | 1 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | |||||
Prepaid Expense And Other Assets Current | 1 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Inventory Net | 0 | 0 | 0 | - | - | - | - | - | - | - | - | - | |||||
Other Receivables | - | - | - | - | - | 0 | 0 | 0 | - | - | - | - | |||||
Assets | 7 | 1 | 2 | 1 | 2 | 0 | 7 | 7 | 20 | 20 | 20 | 21 | |||||
Liabilities And Stockhold… | |||||||||||||||||
Other Liabilities Current | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Accounts Payable And Accrued Liabilities Current | - | - | - | - | - | 1 | 1 | 1 | 0 | 0 | 0 | 0 | |||||
Notes And Loans Payable Current | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 | - | - | |||||
Accounts Payable Current | 1 | 1 | 1 | 1 | 1 | 0 | - | - | - | - | - | - | |||||
Liabilities Current | |||||||||||||||||
Assets Held In Trust Noncurrent | - | - | - | - | - | 7 | 7 | 7 | 20 | 20 | 20 | 20 | |||||
Liabilities Current | 3 | 8 | 14 | 11 | 10 | 2 | 7 | 6 | 3 | 0 | 0 | 0 | |||||
Accrued Liabilities Current | 0 | 1 | 0 | 0 | 0 | - | - | - | - | - | - | - | |||||
Notes Payable Current | - | - | - | 1 | 1 | - | - | - | - | - | - | - | |||||
Loans Payable Current | - | - | - | 0 | 0 | - | - | - | - | - | - | - | |||||
Derivative Liabilities Current | - | 0 | 4 | - | - | - | - | - | - | - | - | - | |||||
Convertible Debt Current | - | 1 | 5 | 4 | 3 | - | - | - | - | - | - | - | |||||
Liabilities | 3 | 8 | 14 | 11 | 10 | 2 | 7 | 6 | 3 | 0 | 0 | 0 | |||||
Temporary Equity Carrying Amount Attributable To P… | - | - | - | - | - | 7 | 7 | 7 | 20 | 20 | 20 | 20 | |||||
Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - | - | - | - | |||||
Stockholders Equity | |||||||||||||||||
Additional Paid In Capital | 34 | 21 | 11 | 11 | 11 | 1 | 9 | 9 | 11 | 11 | 11 | 11 | |||||
Stockholders Equity | 4 | -6 | -11 | -10 | -8 | -2 | -1 | -1 | -0 | -0 | -0 | 0 | |||||
Retained Earnings Accumulated Deficit | -30 | -27 | -23 | -21 | -19 | -3 | -15 | -15 | -14 | -11 | -11 | -11 | |||||
Liabilities And Stockholders Equity | 7 | 1 | 2 | 1 | 2 | 0 | 7 | 7 | 20 | 20 | 20 | 21 | |||||
Common Classa Subject To Redemption | - | - | - | - | - | - | - | - | - | - | - | 2 | |||||
Common Classa Not Subject To Redemption | - | - | - | - | - | - | - | - | - | - | - | 7 | |||||
Common Class B | - | - | - | - | - | - | - | - | - | - | - | -7 | |||||
Common Class A Subject To Redemption | - | - | - | - | - | - | 0 | 0 | - | - | - | - | |||||
Preferred Stock Par Or Stated Value Per Share | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Preferred Stock Shares Authorized | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | |||||
Preferred Stock Shares Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Preferred Stock Shares Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Common Stock Par Or Stated Value Per Share | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - | 0 | - | - | |||||
Common Stock Shares Authorized | 490 | 490 | 490 | 490 | 490 | 490 | - | - | - | - | - | - | |||||
Common Stock Shares Issued | 0 | 0 | 5 | 5 | 5 | 0 | - | - | - | - | - | - | |||||
Shares Outstanding | 0 | 0 | 5 | 5 | 5 | 0 | - | - | - | - | - | - | |||||
Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables
Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables
Custom Table
Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals
Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals
Interactive Financial Visualizations
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Earnings Market Reaction
| Fiscal Year | Q1 1 Month | Q1 2 Month | Q1 3 Month | Q2 1 Month | Q2 2 Month | Q2 3 Month | Q3 1 Month | Q3 2 Month | Q3 3 Month | Q4 1 Month | Q4 2 Month | Q4 3 Month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -4.81% | 10.70% | - | - | - | - | - | - | - | - | - | - |
| 2025 | 60.08% | 22.69% | 51.26% | 28.32% | -3.76% | -4.01% | -13.21% | 29.25% | -49.76% | -78.42% | 469.47% | 592.63% |
| 2024 | -0.88% | -1.06% | -1.23% | 0.00% | 10.51% | 1.60% | -1.41% | -1.58% | 11.62% | -15.21% | 7.23% | -28.93% |
| 2023 | - | - | - | 3.79% | 2.65% | 2.89% | -0.46% | -0.18% | 0.37% | 0.18% | 1.20% | 1.81% |
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial | ||||||||||||
Subscribe to unlock 17+ years of financial data and 50+ calculated metrics
Subscribe to unlock 17+ years of data and 50+ calculated metrics
Performance and Valuation Metrics
Metrics | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Liquidity Ratios | |||||||||||||||||
| Current Ratio | 2.26 | 0.17 | 0.17 | 0.09 | 0.20 | 0.09 | 0.01 | 0.05 | 0.02 | 0.20 | 0.80 | 1.92 | |||||
| Quick Ratio | 1.86 | 0.13 | 0.14 | 0.02 | 0.14 | 0.00 | 0.00 | 0.05 | 0.00 | 0.00 | 0.00 | 0.44 | |||||
| Working Capital | 3.96M | -6.28M | -11.46M | -9.57M | -7.90M | -1.54M | -6.51M | -5.90M | -2.57M | -322.11K | -62.95K | 261.79K | |||||
Leverage & Debt | |||||||||||||||||
| Debt to Equity | 0.84 | -1.21 | -1.21 | -1.10 | -1.25 | -1.10 | -8.49 | -11.18 | -5.38 | -1.25 | -5.02 | 1.09 | |||||
| Interest Coverage TTM | -13.06 | -25.44 | -23.42 | -22.28 | -58.17 | -9.39 | -4.79 | -3.99 | 6.42 | - | - | - | |||||
| Debt Ratio | 0.46 | 5.86 | 5.77 | 10.72 | 5.05 | 11.41 | 0.99 | 0.91 | 0.13 | 0.02 | 0.02 | 0.01 | |||||
Efficiency & Turnover | |||||||||||||||||
| Asset Turnover TTM | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
Per Share Metrics | |||||||||||||||||
| Diluted EPS TTM | -75.07 | -163.76 | -4.15 | -3.83 | -5.39 | -18.99 | -10.07 | -7.94 | 19.72 | 54.24 | - | 100.68 | |||||
| Free Cash Flow Per Share TTM | -39.64 | -32.93 | -0.71 | -0.59 | -0.58 | -3.84 | -13.06 | -7.68 | -9.62 | -7.93 | - | -5.73 | |||||
| Dividend Per Share TTM | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | - | 0.00 | |||||
Margin Metrics | |||||||||||||||||
| Operating Profit Margin TTM | -15,745.85% | -312,016.95% | -911,777.02% | - | - | - | - | - | - | - | - | - | |||||
| Net Profit Margin TTM | -34,039.68% | -394,725.06% | -1,058,156.83% | - | - | - | - | - | - | - | - | - | |||||
Growth Metrics | |||||||||||||||||
| Net Income Growth (1Y) | -30.89% | 1,768.95% | 2,854.91% | 3,349.34% | -1,350.87% | -129.34% | -110.15% | -106.86% | -78.40% | 33.65% | - | - | |||||
| EPS Growth (1Y) | 1,292.67% | 762.51% | -58.83% | -51.75% | -127.33% | -135.01% | - | -107.89% | -77.50% | -0.56% | - | - | |||||
Valuation Metrics | |||||||||||||||||
| P/E TTM | -0.01 | -0.03 | -1.99 | -2.81 | -4.33 | -24.23 | -48.49 | -56.76 | 22.34 | 8.03 | - | 4.14 | |||||
| P/B | 0.04 | -0.12 | -3.56 | -5.52 | -9.26 | -20.61 | -43.52 | -55.74 | -62.07 | -111.31 | - | 126.38 | |||||
| P/S TTM | 4.67 | 127.27 | 21,024.93 | - | - | - | - | - | - | - | - | - | |||||
| Market Cap | 161.39K | 789.34K | 40.81M | 53.08M | 73.63M | 31.74M | 33.70M | 31.11M | 30.40M | 35.85M | - | 33.08M | |||||
| Enterprise Value | -5.70M | 1.08M | 43.60M | 58.32M | 77.17M | 31.73M | 33.69M | 31.09M | 30.35M | 35.85M | - | 32.96M | |||||
Calculated Values | |||||||||||||||||
| Free Cash Flow TTM | -6.21M | -4.92M | -3.52M | -2.91M | -1.82M | -265.19K | -900.88K | -530.26K | -663.97K | -653.11K | -532.85K | -454.55K | |||||
| Net Debt | -5.86M | 286.57K | 2.79M | 5.24M | 3.54M | -3.63K | -16.54K | -19.60K | -47.29K | 0.00 | -280.00 | -125.20K | |||||
Per-Share and Margin | |||||||||||||||||
| EPS TTM | |||||||||||||||||
| Adjusted EPS TTM | |||||||||||||||||
| Cash Flow Per Share TTM | |||||||||||||||||
| Pretax Margin TTM | |||||||||||||||||
| Stock Comp to Revenue TTM | |||||||||||||||||
Turnover Ratios and Averages | |||||||||||||||||
| Average Assets | |||||||||||||||||
| Average Equity | |||||||||||||||||
| Average Inventory | |||||||||||||||||
| Average Receivables | |||||||||||||||||
| Average Accounts Payables | |||||||||||||||||
| Inventory Turnover TTM | |||||||||||||||||
| Payables Turnover TTM | |||||||||||||||||
| Days Inventory Outstanding TTM | |||||||||||||||||
| Days Payables Outstanding TTM | |||||||||||||||||
| Cash Conversion Cycle TTM | |||||||||||||||||
| Working Capital to Revenue | |||||||||||||||||
| Deferred Revenue to Revenue | |||||||||||||||||
Growth Rates | |||||||||||||||||
| Total Assets Growth (1Y) | |||||||||||||||||
| Total Assets Growth (3Y) | |||||||||||||||||
| Total Assets Growth (5Y) | |||||||||||||||||
| Dividends Paid Growth (1Y) | |||||||||||||||||
| Dividends Paid Growth (3Y) | |||||||||||||||||
| Dividends Paid Growth (5Y) | |||||||||||||||||
| EPS Growth (3Y) | |||||||||||||||||
| EPS Growth (5Y) | |||||||||||||||||
| Net Income Growth (3Y) | |||||||||||||||||
| Net Income Growth (5Y) | |||||||||||||||||
| Net Profit Margin Growth (1Y) | |||||||||||||||||
| Net Profit Margin Growth (3Y) | |||||||||||||||||
| Net Profit Margin Growth (5Y) | |||||||||||||||||
| Net Revenue Growth (3Y) | |||||||||||||||||
| Net Revenue Growth (5Y) | |||||||||||||||||
| Deferred Revenue Growth (1Y) | |||||||||||||||||
| Retained Earnings Growth (1Y) | |||||||||||||||||
Credit, Liquidity, Returns, Payout | |||||||||||||||||
| Cash Ratio | |||||||||||||||||
| Net Working Capital | |||||||||||||||||
| Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to Equity | |||||||||||||||||
| Altman A | |||||||||||||||||
| Altman B | |||||||||||||||||
| Altman C | |||||||||||||||||
| Altman D | |||||||||||||||||
| Altman E | |||||||||||||||||
| Altman Z-Score | |||||||||||||||||
| ROA TTM | |||||||||||||||||
| ROE TTM | |||||||||||||||||
| NOPAT TTM | |||||||||||||||||
| ROIC TTM | |||||||||||||||||
| Effective Tax Rate TTM | |||||||||||||||||
| Payout Ratio TTM | |||||||||||||||||
| Dilution Ratio | |||||||||||||||||
| Retained Earnings to Equity | |||||||||||||||||
| Treasury Stock to Equity | |||||||||||||||||
| Treasury Stock Change (1Y) | |||||||||||||||||
| Accrued to Current Liabilities | |||||||||||||||||
Valuation Ratios | |||||||||||||||||
| P/CF TTM | |||||||||||||||||
| Dividend Yield TTM | |||||||||||||||||
| Free Cash Flow Yield TTM | |||||||||||||||||
| EV EBITDA TTM | |||||||||||||||||
| EV EBIT TTM | |||||||||||||||||
| Stock Compensation TTM | |||||||||||||||||
| Adjusted Net Income TTM | |||||||||||||||||
| Billings TTM | |||||||||||||||||
| Total Debt | |||||||||||||||||
| Invested Capital | |||||||||||||||||
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Insider Transactions
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data